Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2020 > Vol 1, №1 (2020) > Cardiac sarcoidosis manifestations

Cardiac sarcoidosis manifestations

Olga Yu. Karpova , Leonid I. Dvoretsky

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Patient with pulmonary sarcoidosis and signs of cardiac involvement under the lung symptoms improvement: case report. The possible cause of cardiac symptoms (granulomatous inflammatory response, myocardial fibrosis) is discussed. The data on morbidity, clinical manifestations and cardiac lesion diagnosis in patients with sarcoidosis is reported. The need for the heart lesion signs thorough search for the purpose of early diagnosis and adequate therapy is emphasized.

Key words: sarcoidosis, cardiac sarcoidosis, cardiac sarcoidosis diagnosis.

About the Author

Olga Yu. Karpova 1 , Leonid I. Dvoretsky 1

1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

References

1. Vizel АА, Vizel IYu, Amirov NB. Epidemiology of sarcoidosis in the Russian Federation. The Bulletin of Contemporary Clinical Medicine 2017; 10 (5): 66–73. DOI: 10.20969/VSKM.2017.10(5).66-73
2. Ungprasert P, Crowson CS, Matteson EL. Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota. Reumatismo 2017; 69 (1): 16–22.
3. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest 1993; 103: 253–8.
4. Matsui Y, Iwai K, Tachibana T еt al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976; 278: 455–69.
5. Nirav Patel, Rajat Kalra, Rajkumar Doshi et al. Hospitalization Rates, Prevalence of Cardiovascular Manifestations, and Outcomes Associated With Sarcoidosis in the United States. J Am Heart Assoc 2018; 7 (2): 1–10.
6. Nagano N, Nagai T, Sugano Y, et al. Association between basal thinning of interventricular septum and adverse long‐term clinical outcomes in patients with cardiac sarcoidosis. Circ J 2015; 79 (7): 1601–8.
7. Dae‐Won Sohn, Jun‐Bean Park, Seung‐Pyo Lee et al. Viewpoints in the diagnosis and treatment of sarcoidosis: proposed modification of current guidelines. Clin Cardiol 2018; 41 (10): 1386–94.
8. Roberts WC, Chung MS, Ko JM et al. Morphologic features of cardiac sarcoidosis in native hearts of patients having cardiac transplantation. Am J Cardiol 2014; 113: 706–12.
9. Fumio Terasaki, Keiichiro Yoshinaga. New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan. Ann Nucl Med 2017; 3 (1): 42–5.
10. Kanaroglou S, Nair V, Fernandes JR. Sudden cardiac death due to coronary artery dissection as a complication of cardiac sarcoidosis. Cardiovasc Pathol 2015; 24: 244–6.
11. Bons JA, Drent M, Bouwman FG et al. Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum. Respir Med 2007; 101: 1687–95.
12. Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis 1993; 148: 483–6.
13. Ruth GM Keijsers, Jan C Grutters. In Which Patients with Sarcoidosis Is FDG PET/CT indicated? J Clin Med 2020; 9 (3): 890.

For citation:Karpova O.Y., Dvoretsky L.I. Cardiac sarcoidosis manifestations. Clinical review for general practice. 2020; 1: 42–48. DOI: 10.47407/kr2020.1.1.00007


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru